Category: Biotechnology
Global Biotechnology
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More
-
ADME-Toxicology Testing
... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More
-
Commercial Biotechnology Separation Systems
... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Conventional, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$19.0 Billion by the end ... Read More
-
RNA Analysis / Transcriptomics
... 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$9.7 Billion by ... Read More
-
Nanopatterning
... 17.7% over the analysis period 2024-2030. UV Nanoimprint Lithography, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$6.2 Billion by the end of the analysis period. ... Read More
-
Process Spectroscopy
... CAGR of 6.6% over the analysis period 2024-2030. Hardware, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$26.2 Billion by the end of the analysis period. ... Read More
-
Baking Enzymes
... CAGR of 5.0% over the analysis period 2024-2030. Carbohydrase, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$866.5 Million by the end of the analysis period. ... Read More
-
Cell Culture Protein Surface Coating
... Billion by 2030, growing at a CAGR of 15.3% over the analysis period 2024-2030. Animal-Derived Protein, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.5 Billion ... Read More
-
Cell Expansion
... CAGR of 14.8% over the analysis period 2024-2030. Cell Expansion Consumables, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$42.4 Billion by the end of the ... Read More
-
Chromatographic Silica Resins
... at a CAGR of 3.6% over the analysis period 2024-2030. Ultrapure Silica (Up To 99%), one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$96.2 Million by ... Read More
-
Regenerative Medicine
... CAGR of 15.7% over the analysis period 2024-2030. Cell Therapy, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$16.9 Billion by the end of the analysis ... Read More
-
Nanophotonics
... 38.1% over the analysis period 2024-2030. LED, one of the segments analyzed in the report, is expected to record a 42.0% CAGR and reach US$227.1 Billion by the end of the analysis period. Growth in ... Read More
-
Agrigenomics
... 8.1% over the analysis period 2024-2030. Illumina Hi Seq Family, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$3.5 Billion by the end of the analysis ... Read More
-
Bioburden Testing
... CAGR of 11.3% over the analysis period 2024-2030. Bioburden Testing Consumables, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Biologics Safety Testing
... at a CAGR of 11.8% over the analysis period 2024-2030. Biologics Safety Testing Services, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$5.5 Billion by the ... Read More
-
CAR T-cell Therapy
... at a CAGR of 22.0% over the analysis period 2024-2030. DLBCL Indication, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$5.1 Billion by the end of ... Read More
-
Acoustic Microscopy
... CAGR of 5.5% over the analysis period 2024-2030. Acoustic Microscopy Services, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$918.5 Million by the end of the ... Read More
-
Chiral Technology
... CAGR of 3.6% over the analysis period 2024-2030. Intermediates, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.2 Billion by the end of the analysis period. ... Read More
-
Growth Factors (Blood and Tissue)
... Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Interferons, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$78.2 Billion by ... Read More
-
Cancer Gene Therapy
... at a CAGR of 20.9% over the analysis period 2024-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$4.3 Billion by the end of ... Read More
-
Genetic Testing
... CAGR of 9.9% over the analysis period 2024-2030. Cancer, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$13.6 Billion by the end of the analysis period. ... Read More
-
Small Molecule Kinase Inhibitors
... 2030, growing at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$27.8 Billion While China is Forecast to Grow at 14.6% CAGR The Small Molecule Kinase Inhibitors market ... Read More
-
Gas Chromatography Systems
... at a CAGR of 4.9% over the analysis period 2024-2030. Accessories & Consumables, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.8 Billion by the end ... Read More
-
HPLC Systems and Accessories
... 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Pumps, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.7 Billion by the end ... Read More
-
Pipettes and Pipettors
... at a CAGR of 5.7% over the analysis period 2024-2030. Pipette Tips, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.5 Billion by the end of ... Read More
Research Assistance
